ALKBH5 and cancer: In addition, Zhang et al. showed that blocking ALKBH5 in GBMSCs, using an shRNA strategy, affects m6A global levels [14], suggesting that high expression of ALKBH5 might be more widely associated with general pathways involved in hallmarks of cancers.